Business
Press Release Dec 22 2022
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 22, 2022, titled "Alembic Pharmaceuticals announces its first product approval from its Formulation Division IV, Jarod Facility".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 22, 2022, titled \"Alembic Pharmaceuticals announces its first product approval from its Formulation Division IV, Jarod Facility\". View Attachment","length":404,"tagName":"div"}]